Novo Nordisk's Q3 2026 beat and overlooked guidance upgrades make medium-term de-rating exceedingly unlikely. Click for more ...

Alphabet's first Hong Kong and Singapore dollar bond sales draw about $5B in orders, including arrangers; initial yield ...

Jensen Huang’s future at Nvidia is becoming a prediction-market wager, with traders raising the odds of his departure as ...

President Trump's decision to import Russian diesel helped Moscow double its exports of the fuel last month, but none of the ...

Markets are anxious about near-term inflation surprises but seem to view structural inflation benignly. Long-term market ...

Review the Q3 2026 commentary for Voya Small Cap Growth Strategy detailing top performance detractors and contributors. Read ...

Strategy Q3 2026 update highlights key detractors, contributors, and market outlook. Read the full commentary to learn more.

Medtronic expands its heart-rhythm business with Affera and PulseSelect, driving material revenue growth. Find out why MDT ...

The U.S. CRE Health Index currently scores U.S. commercial real estate at 46 out of 100, placing the market on the slightly ...

A.O. Smith remains a Hold as the China divestiture unlocks $350M potential returns but does not resolve valuation concerns.

The bull case for MDA Space: orbital radar and defense capabilities, a strong balance sheet and relative valuation support ...

NICE's $955M Cognigy acquisition is integrated into CXone, but early revenue contribution and ROI are disappointing. Read why ...